FITLIFE BRANDS, INC.

FTLF ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $17.8M $25.3M $17.9M $20.0M $19.7M $18.1M $12.1M $8.1M
Cost of Revenue $12.7M $15.2M $11.7M $12.9M $12.5M $11.6M $7.9M $6.1M
Gross Profit $5.1M $10.1M $6.3M $7.1M $7.1M $6.5M $4.1M $2.0M
Gross Margin 28.6% 39.8% 35.0% 35.5% 36.2% 36.1% 34.3% 24.9%
Operating Expenses
Research & Development
SG&A Expense $4.2M $5.0M $4.1M $2.6M $3.1M $2.2M $2.1M $3.2M
Operating Income $-9.0M $472.3K $-1.1M $1.9M $1.4M $1.9M $208.7K $-3.1M
Operating Margin -50.3% 1.9% -6.1% 9.3% 7.0% 10.4% 1.7% -38.1%
Interest Expense $112.0K $109.4K $-90.4K $94.7K $40.9K $18.4K $30.9K $-139.8K
Pretax Income $-9.1M $368.1K
Income Tax Expense $689.0K $0 $0 $171.4K $90.5K $-648.7K $0 $0
Net Income $509.0K $368.1K $-1.2M $1.7M $1.3M $2.5M $326.7K $-3.2M
Net Margin 2.9% 1.5% -6.5% 8.4% 6.6% 14.0% 2.7% -39.0%
EPS (Basic) $-0.23 $0.01 $-0.03 $0.05 $0.04 $0.01 $0.00 $-0.01
EPS (Diluted) $-0.23 $0.01 $-0.03 $0.05 $0.04 $0.01 $0.00 $-0.01
Shares Outstanding (Basic) 42.1M 41.4M 34.7M 32.7M 31.3M 297.9M 291.9M 242.6M
Shares Outstanding (Diluted) 42.1M 41.4M 34.7M 34.3M 35.8M 375.1M 376.6M 242.6M
Dividends Per Share
← Newer Page 2 of 2 Older →